Engineering a More Potent Monoclonal Antibody against HIV-1 Gp41 Through Recombination of Complementarity Determining Regions

Presenter
  • A. Rubio
Session
Virtual 321 - AAR04 Antiviral Agents (including HIV Drugs): Mechanisms of Action and Resistance - HIV and HCV Resistance and Therapy